BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35977616)

  • 1. Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study.
    Ingason AB; Hreinsson JP; Agustsson AS; Lund SH; Rumba E; Palsson DA; Reynisson IE; Gudmundsdottir BR; Onundarson PT; Bjornsson ES
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):347-357.e10. PubMed ID: 35977616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants : A Nationwide Propensity Score-Weighted Study.
    Ingason AB; Hreinsson JP; Ágústsson AS; Lund SH; Rumba E; Pálsson DA; Reynisson IE; Guðmundsdóttir BR; Önundarson PT; Björnsson ES
    Ann Intern Med; 2021 Nov; 174(11):1493-1502. PubMed ID: 34633836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
    Tapaskar N; Ham SA; Micic D; Sengupta N
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):381-389.e9. PubMed ID: 33227428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal Bleeding on Oral Anticoagulation: What is Currently Known.
    Ingason AB; Hreinsson JP; Björnsson ES
    Drug Saf; 2022 Dec; 45(12):1449-1456. PubMed ID: 36227528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effectiveness and safety of direct oral anticoagulants: a nationwide propensity score-weighted study.
    Ingason AB; Hreinsson JP; Agustsson AS; Lund SH; Rumba E; Palsson DA; Reynisson IE; Gudmundsdottir BR; Onundarson PT; Bjornsson ES
    Blood Adv; 2023 Jun; 7(11):2564-2572. PubMed ID: 36562754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? - A systematic review and network meta-analysis.
    Radadiya D; Devani K; Brahmbhatt B; Reddy C
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e50-e58. PubMed ID: 33470705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding.
    Lee SR; Kwon S; Choi EK; Jung JH; Han KD; Oh S; Lip GYH
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):679-689. PubMed ID: 33730289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data.
    Hu W; Cai H; Zhang J
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin is associated with higher rates of epistaxis compared to direct oral anticoagulants: A nationwide propensity score-weighted study.
    Ingason AB; Rumba E; Hreinsson JP; Agustsson AS; Lund SH; Palsson DA; Reynisson IE; Gudmundsdottir BR; Onundarson PT; Tryggvason G; Bjornsson ES
    J Intern Med; 2022 Sep; 292(3):501-511. PubMed ID: 35411982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation : A Multinational Population-Based Cohort Study.
    Lau WCY; Torre CO; Man KKC; Stewart HM; Seager S; Van Zandt M; Reich C; Li J; Brewster J; Lip GYH; Hingorani AD; Wei L; Wong ICK
    Ann Intern Med; 2022 Nov; 175(11):1515-1524. PubMed ID: 36315950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Garcia DA; Fisher DA; Mulder H; Wruck L; De Caterina R; Halvorsen S; Granger CB; Held C; Wallentin L; Alexander JH; Lopes RD
    Am Heart J; 2020 Mar; 221():1-8. PubMed ID: 31896036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis.
    Amin A; Keshishian A; Hines DM; Dina O; Le H; Rosenblatt L; Liu X; Zhang Q; Vo L
    Curr Med Res Opin; 2022 Dec; 38(12):2131-2140. PubMed ID: 35993487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
    Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
    Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
    Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding.
    Lip GYH; Keshishian AV; Zhang Y; Kang A; Dhamane AD; Luo X; Klem C; Ferri M; Jiang J; Yuce H; Deitelzweig S
    JAMA Netw Open; 2021 Aug; 4(8):e2120064. PubMed ID: 34398204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.
    Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
    JAMA; 2018 Dec; 320(21):2221-2230. PubMed ID: 30512099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants.
    Ording AG; Søgaard M; Skjøth F; Grove EL; Lip GYH; Larsen TB; Nielsen PB
    Cancer Med; 2021 Jul; 10(13):4405-4414. PubMed ID: 34114733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies.
    He Y; Wong IC; Li X; Anand S; Leung WK; Siu CW; Chan EW
    Br J Clin Pharmacol; 2016 Jul; 82(1):285-300. PubMed ID: 26889922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.
    Shah S; Norby FL; Datta YH; Lutsey PL; MacLehose RF; Chen LY; Alonso A
    Blood Adv; 2018 Feb; 2(3):200-209. PubMed ID: 29378726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.